Skip to content
Hei Āhuru Mōwai, Māori Cancer Leadership Aotearoa
Donate
MenuClose

Pancreatic cancer

On this page: resources published by other organisations, then the research assessed for this site.

This page points at research, and at resources published by other organisations. It is not advice about your own care or treatment.

Published by other organisations

4 booklets and reports published by other organisations. These belong to whoever wrote them and are not hosted here.

The library groups these together with stomach cancer and liver cancer, so some of what follows is about those rather than about pancreatic cancer. Each one is titled by its own publisher.

Research

One paper on pancreatic cancer, from the research assessed for this site. Each is summarised below in words written for this site, not the authors’ own.

  1. Equity of Cancer and Diabetes Co-Occurrence: A National Study With 44 Million Person-Years of Follow-Up (opens on the publisher’s website)

    JCO Global Oncology · 2023

    Jason Gurney, James Stanley, Andrea Teng, Bridget Robson, Nina Scott, Dianne Sika-Paotonu, Chunhuan Lao, Ross Lawrenson, Jeremy Krebs, Jonathan Koea

    What it found
    Linking national health records for close to five million people over 44 million person-years, the study found people with diabetes had higher cancer rates than people without it, in every ethnic group, with Māori carrying both the highest age-standardised rate (1,303.6 per 100,000 person-years) and the highest rate ratio (1.37, against 1.23-1.35 for the other groups measured). Uterine, pancreatic, kidney and liver cancers showed the strongest links to diabetes across all groups. It is a descriptive study: it establishes the size of the co-occurring burden by ethnicity, not why the gap exists.
    How it was done
    retrospective national cohort using linked administrative data, close to 5 million people, 44 million person-years, 2008-2018
    Why it matters
    It gives a population-level size and shape to the diabetes-cancer overlap Māori carry disproportionately, which matters for anyone planning screening or comorbidity care.
    What it does not settle
    Descriptive/observational - no causal claim is made or should be drawn. There is a related but distinct 2022 PLOS ONE paper by an overlapping author group with a very similar title ("Cancer and diabetes co-occurrence: A national study with 44 million person-years of follow-up", DOI 10.1371/journal.pone.0276913) - worth not conflating the two.

    Full textFull text, via the open-access copy at PMC.

    Read it free: Equity of Cancer and Diabetes Co-Occurrence: A National Study With 44 Million Person-Years of Follow-Up (opens on another organisation’s website)DOI 10.1200/GO.22.00357

How this page was put together

The research summaries

Each summary was written for this site, and it is not the authors’ own abstract. None of it has been reviewed by Hei Āhuru Mōwai. It was read in full. Each entry carries the note of what was read, because a summary built from an abstract carries less weight than one built from the paper.

Resources published by other organisations

Each one opens a record on this site naming the publisher, carrying their own note about the edition and about how they are funded where they give one. The document itself is on the publisher’s website. None of it is hosted here, and it remains theirs.

Which of these appear, and how they are grouped, is a choice made for this site. It is not Hei Āhuru Mōwai’s view on what any of them says.

Looking for something else

All cancer types, or the whole library at Rauemi.

If you cannot find what you are after, get in touch.